Bone complications of mastocytosis: A link between clinical and biological characteristics

American Journal of Medicine

Volumn 126, Issue 1, 2013, Pages

  Guillaume, Nicolas ^a   Desoutter, Judith ^a   Chandesris, Olivia ^c   Merlusca, Lavinia ^a   Henry, Isabelle ^a   Georgin Lavialle, Sophie ^c,d   Barete, Stéphane ^e   Hirsch, Isabelle ^c   Bouredji, Daoud ^f   Royer, Bruno ^a   Gruson, Bérengère ^a   Lok, Catherine ^a   Sevestre, Henri ^a   Mentaverri, Romuald ^g   Brazier, Michel ^a,g   Meynier, Jonathan ^a   Hermine, Olivier ^b,c   Marolleau, Jean Pierre ^a   Kamel, Said ^g   Damaj, Gandhi ^a,c  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f General Hospital   (France)

^g UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

Bone remodeling; Mastocytosis; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; CARBOXY TERMINAL TELOPEPTIDE; DEOXYPYRIDINOLINE; OSTEOPROTEGERIN; TRYPTASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE DENSITY; BONE PAIN; BONE RADIOGRAPHY; BONE REMODELING; BONE TURNOVER; CLINICAL ARTICLE; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MAST CELL; MASTOCYTOSIS; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; FEMALE; HUMANS; MALE; MASTOCYTOSIS; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TRYPTASES; YOUNG ADULT;

EID: 84871619423     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.07.018     Document Type: Article

References (20)

1. H.P. Horny, K. Sotlar, P. Valent Mastocytosis: state of the art Pathobiology 74 2 2007 121 132
2. P. Valent, H.P. Horny, L. Escribano Diagnostic criteria and classification of mastocytosis: a consensus proposal Leuk Res 25 7 2001 603 625
3. L.B. Schwartz Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders Leuk Res 25 7 2001 553 562
4. S. Barete, N. Assous, C. de Gennes Systemic mastocytosis and bone involvement in a cohort of 75 patients Ann Rheum Dis 69 10 2010 1838 1841
5. N. Chiappetta, B. Gruber The role of mast cells in osteoporosis Semin Arthritis Rheum 36 1 2006 32 36
6. C. de Gennes, D. Kuntz, M.C. de Vernejoul Bone mastocytosis A report of nine cases with a bone histomorphometric study Clin Orthop Relat Res 279 1992 281 291
7. T.D. Rachner, S. Khosla, L.C. Hofbauer Osteoporosis: now and the future Lancet 377 9773 2011 1276 1287
8. World Health Organization (WHO) WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level: Summary Meeting Report, Brussels, Belgium, 5-7 May 2004 2007 WHO Geneva, Switzerland
9. E.M. Lewiecki, C.M. Gordon, S. Baim International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions Bone 43 6 2008 1115 1121
10. L.J. Melton 3rd, S. Khosla, E.J. Atkinson, W.M. O'Fallon, B.L. Riggs Relationship of bone turnover to bone density and fractures J Bone Miner Res 12 7 1997 1083 1091
11. M. Rossini, R. Zanotti, P. Bonadonna Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis Bone 49 4 2011 880 885
12. S.H. Swerdlow, E. Campo, N.L. Harris WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 International Agency for Research on Cancer Lyon, France
13. J.A. Kanis Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report WHO Study Group Osteoporos Int 4 6 1994 368 381
14. L.G. Raisz Pathogenesis of osteoporosis: concepts, conflicts, and prospects J Clin Invest 115 12 2005 3318 3325
15. P. Garnero, E. Hausherr, M.C. Chapuy Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study J Bone Miner Res 11 10 1996 1531 1538
16. E. Biver, F. Chopin, G. Coiffier Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis Joint Bone Spine 79 1 2012 20 25
17. E.V. McCloskey, S. Vasikaran, C. Cooper FRAX® Position Development Conference Members Official Positions for FRAX® clinical regarding biochemical markers from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX® J Clin Densitom 14 3 2011 220 222
18. S. Jabbar, J. Drury, J.N. Fordham, H.K. Datta, R.M. Francis, S.P. Tuck Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis J Clin Pathol 64 4 2011 354 357
19. R. Silberstein, M. Melnick, G. Greenberg, C. Minkin Bone remodeling in W/Wv mast cell deficient mice Bone 12 4 1991 227 236
20. M. Biosse-Duplan, B. Baroukh, M. Dy, M.C. de Vernejoul, J.L. Saffar Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts Am J Pathol 174 4 2009 1426 1434